1-(1-(4-bromophenyl)-2-(1H-1,2,4-triazol-1-yl)ethylidene)-2-(4-(4-fluorophenyl)thiazol-2-yl)hydrazine | 1394137-27-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-(1-(4-bromophenyl)-2-(1H-1,2,4-triazol-1-yl)ethylidene)-2-(4-(4-fluorophenyl)thiazol-2-yl)hydrazine
• 英文别名: N-[[1-(4-bromophenyl)-2-(1,2,4-triazol-1-yl)ethylidene]amino]-4-(4-fluorophenyl)-1,3-thiazol-2-amine
• CAS: 1394137-27-9
• 化学式: C₁₉H₁₄BrFN₆S
• 分子量: 457.329
• InChiKey: KGIQBJNWCOZKSU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.82
• 重原子数：
  28.0
• 可旋转键数：
  6.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  67.99
• 氢给体数：
  1.0
• 氢受体数：
  7.0

反应信息

• 作为产物：
  描述：

  1-(4-溴苯基)-2-(1,2,4-三唑-1-基)乙酮 在 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 1.25h， 生成 1-(1-(4-bromophenyl)-2-(1H-1,2,4-triazol-1-yl)ethylidene)-2-(4-(4-fluorophenyl)thiazol-2-yl)hydrazine
  参考文献：
  名称：

  Hybrids of ravuconazole: Synthesis and biological evaluation

  摘要：

  In continuation of our work on antimicrobial agents, a number of hybrid molecules 4a-y containing thiazole and triazole pharmacophores were designed and synthesized. The structure of the compounds was established by IR, NMR, MS and CHN analysis. All the synthesized compounds were tested for qualitative (Zone of inhibition) and quantitative (MIC) antimicrobial activities against four pathogenic bacteria Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and two pathogenic fungi Candida albicans and Aspergillus niger. Of all the synthesized compounds screened, most of them show potent antimicrobial activity against Gram positive and Gram negative bacteria as well as the fungi species. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.05.010

文献信息

• Hybrids of ravuconazole: Synthesis and biological evaluation
  作者：Nitin D. Gaikwad、Sachin V. Patil、Vivek D. Bobade

  DOI：10.1016/j.ejmech.2012.05.010

  日期：2012.8

  In continuation of our work on antimicrobial agents, a number of hybrid molecules 4a-y containing thiazole and triazole pharmacophores were designed and synthesized. The structure of the compounds was established by IR, NMR, MS and CHN analysis. All the synthesized compounds were tested for qualitative (Zone of inhibition) and quantitative (MIC) antimicrobial activities against four pathogenic bacteria Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and two pathogenic fungi Candida albicans and Aspergillus niger. Of all the synthesized compounds screened, most of them show potent antimicrobial activity against Gram positive and Gram negative bacteria as well as the fungi species. (C) 2012 Elsevier Masson SAS. All rights reserved.